OXURION (EBR:OXUR) | WebDisclosure

BRIEF

published on 05/15/2025 at 18:05, 1 year 4 months ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Acquisition Actions Transparency Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 05/15/2025 at 18:00, 1 year 4 months ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV announces receipt of transparency notifications regarding changes in shareholding percentages to comply with Belgian transparency legislation. Details in attached PDF file

Shareholding Oxurion NV Belgian Legislation Transparency Notifications PDF File
PRESS RELEASE

published on 05/15/2025 at 18:00, 1 year 4 months ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion announces receipt of transparency notifications regarding share ownership by Atlas Special Opportunities II, LLC, crossing thresholds under and above 5% and 25%

Share Ownership Thresholds Oxurion Atlas Special Opportunities II Transparency Notifications
BRIEF

published on 05/12/2025 at 18:05, 1 year 4 months ago

Oxurion Reports Shares Threshold Crossings by Atlas Special Opportunities

Transparency Notification Atlas Special Opportunities Oxurion Shareholding Thresholds Retinal Disease Therapies
BRIEF

published on 05/12/2025 at 18:05, 1 year 4 months ago

Oxurion annonce des franchissements de seuils d'actions par Atlas Special Opportunities

Notification De Transparence Oxurion Opportunités Spéciales Atlas Seuils De Participation Thérapies Contre Les Maladies Rétiniennes
PRESS RELEASE

published on 05/12/2025 at 18:00, 1 year 4 months ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV received transparency notifications regarding changes in shareholding percentages from Atlas Special Opportunities II, LLC. The biopharmaceutical company is focused on developing ophthalmic therapies for retinal disease

Biopharmaceutical Shareholding Changes Ophthalmic Therapies Oxurion NV Transparency Notifications
PRESS RELEASE

published on 05/12/2025 at 18:00, 1 year 4 months ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC over aandelentransacties en voldoet aan Belgische transparantiewetgeving. Het biofarmaceutisch bedrijf ontwikkelt oftalmologische therapieën

Transparantiekennisgevingen Oxurion NV Oftalmologische Therapieën Belgische Transparantiewetgeving Biofarmaceutisch Bedrijf
BRIEF

published on 05/09/2025 at 18:05, 1 year 4 months ago

Oxurion Increases Capital Following Convertible Bond Conversion

Convertible Bonds Capital Increase Atlas Special Opportunities Vision Preservation Oxurion Shares
BRIEF

published on 05/09/2025 at 18:05, 1 year 4 months ago

Oxurion augmente son capital suite à la conversion d'obligations convertibles

Obligations Convertibles Augmentation De Capital Opportunités Spéciales Atlas Préservation De La Vision Actions Oxurion
PRESS RELEASE

published on 05/09/2025 at 18:00, 1 year 4 months ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converts 4 convertible bonds in Oxurion, resulting in EUR 100,000 capital increase, supporting innovative therapeutics development for vision preservation in elderly. Oxurion shares update post-capital increase

Capital Increase Oxurion Atlas Special Opportunities, LLC Innovative Therapeutics Vision Preservation

Published on 09/26/2026 at 01:00, 9 hours 49 minutes ago

Guanajuato Silver Renews Base Shelf Prospectus
Published on 09/26/2026 at 01:00, 9 hours 49 minutes ago

Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 12 hours 34 minutes ago

Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 17 hours 19 minutes ago

Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 19 hours 49 minutes ago

HM Exploration Provides Program Update for the Lewis Pilley's Project

View all ACCESSWIRE

Published on 09/26/2026 at 07:45, 3 hours 4 minutes ago

Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe
Published on 09/26/2026 at 00:01, 10 hours 48 minutes ago

Photon Energy N.V. Sells 7.6 MWp of PV Operational Assets in Slovakia
Published on 09/25/2026 at 18:30, 16 hours 19 minutes ago

029 Group SE: Publication of Half-Year Report 2026
Published on 09/25/2026 at 18:15, 16 hours 34 minutes ago

Warren Wise decodes Qiagen’s DNA
Published on 09/25/2026 at 18:00, 16 hours 49 minutes ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26

View all EQS

Published on 09/26/2026 at 07:00, 3 hours 49 minutes ago

Groupe DLSI - Résultat 1er semestre 2026
Published on 09/25/2026 at 18:00, 16 hours 49 minutes ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 18:00, 16 hours 49 minutes ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 17:45, 17 hours 4 minutes ago

COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 17 hours 9 minutes ago

Availability of the 2026 half-year financial report

View all LES ECHOS COMFI WIRE

News